Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
Public ClinicalTrials.gov record NCT01176006. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Related and Unrelated Donor Hematopoietic Stem Cell Transplant for DOCK8 Deficiency
Study identification
- NCT ID
- NCT01176006
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Interventions
- Bone Marrow Harvest Procedure Procedure
- Busulfan (Busulfex) Drug
- Cyclophosphamide(CTX, Cytoxan) Drug
- Donor peripheral blood stem cell mobiliation and collection Procedure
- Fludarabine(Fludara, Berlex Laboratories) Drug
- Reduced-intensity hematopoietic stem cell Procedure
- Total Body Irradiation (TBI) Procedure
Procedure · Drug
Eligibility (public fields only)
- Age range
- 4 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2010
- Primary completion
- Oct 30, 2026
- Completion
- Oct 30, 2028
- Last update posted
- Apr 30, 2026
2010 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01176006, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2026 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01176006 live on ClinicalTrials.gov.